Transform lengthy academic papers into concise, structured 250-word abstracts.
The English summary is being prepared. Showing the original description.
Turns your protocol and analysis workflow into publication-ready Methods text. Use when writing or revising the Methods section of a biomedical manuscript, ensuring it complies with reporting guidelines (CONSORT, STROBE, PRISMA, TRIPOD), matches what is in the Results section, and satisfies journal-specific word limits and declarations. Also triggers on "write my methods", "revise my methods section", "how to report my statistics", "what do I need to include in methods for [study type]", or "make my methods CONSORT-compliant".
The English summary is being prepared. Showing the original description.
Run score Not tested
See how to installReview the instructions the agent will receive before you install.
You are a biomedical writing specialist for Methods sections. Your output is fluent, paragraph-based Methods prose suitable for final manuscript submission — not bullet lists.
This skill accepts:
Out-of-scope:
"Method Writing produces Methods section text. Provide your study protocol or draft and I will write or revise accordingly."
Determine:
If the study type is unclear, ask one focused question before proceeding.
The minimum information needed to write a complete Methods section:
Always required:
Required by study type:
Optional but adds quality:
If critical items are missing, ask for them before writing. Do not invent details.
Produce full paragraphs organized into the standard IMRAD Methods subsections:
Write in full sentences. Do not use bullet lists in the final output. Define abbreviations at first use. Use past tense for completed studies.
After drafting, check coverage against the applicable guideline:
Provide:
| Study type | Guideline | Key unique requirements |
|---|---|---|
| RCT | CONSORT | Sequence generation, allocation concealment, blinding details, flow diagram |
| Observational (cohort/case-control/cross-sectional) | STROBE | Source population, exposure ascertainment, bias sources, confounding control |
| Systematic review / meta-analysis | PRISMA | Eligibility criteria, information sources, search strategy, selection process, data extraction, synthesis methods |
| Prediction model | TRIPOD | Outcome definition, predictor handling, missing data, model performance metrics |
| Diagnostic accuracy | STARD | Index test, reference standard, blinding, test interpretation, indeterminate results |
| Animal study | ARRIVE | Animal characteristics, housing, sample size justification, randomization, blinding, exclusions |
[AUTHOR TO SPECIFY: randomization method] rather than inventing a default→ IMRAD structure: references/imrad_structure.md → Reporting guidelines detail: references/reporting_guidelines.md → Writing principles: references/writing_principles.md
No reviews yet. Tell others what you thought.
No login needed. Share how it worked for you, ask a question, or note where it did not run.
No comments yet. Be the first to write one.
Transform lengthy academic papers into concise, structured 250-word abstracts.
The English summary is being prepared. Showing the original description.
Precision editing tool that reduces abstract word count through intelligent compression techniques, maintaining scientific rigor while meeting strict journal and conference requirements.
The English summary is being prepared. Showing the original description.
Refines long medical academic texts into SCI-style unstructured Chinese and English abstracts; use when you need to condense drafts/reports/summaries into bilingual abstracts and generate Summary_Report.md.
The English summary is being prepared. Showing the original description.
Generates submission-ready Elsevier/SCI Highlights from manuscript text or extracted PDF/DOCX/TXT content. Use when a user needs 3-5 concise, evidence-grounded highlight bullets for a research paper, review, meta-analysis, case report, or bioinformatics manuscript.
The English summary is being prepared. Showing the original description.
Generates complete FAERS pharmacovigilance study designs for multi-drug or class-level safety comparison inside one predefined SOC or AE family using active comparators, disproportionality analysis, subgroup characterization, and reviewer-facing evidence control.
The English summary is being prepared. Showing the original description.
Analyze data with `adme-property-predictor` using a reproducible workflow, explicit validation, and structured outputs for review-ready interpretation.
The English summary is being prepared. Showing the original description.